Federal grants to Resvita Bio Inc
Resvita Bio Inc in Emeryville, California received $2.5 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Arthritis, Musculoskeletal and Skin Diseases Research, with $2.3 million. In fiscal 2025 it was awarded $703,229.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$2.5 million
- Awards3
- Awarded in FY 2025$703,229
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $249,935 |
| FY 2023 | 1 | $249,935 |
| FY 2024 | 1 | $1.3 million |
| FY 2025 | 1 | $703,229 |
Programs that fund Resvita Bio Inc
| Program | Awards | Amount |
|---|---|---|
| Arthritis, Musculoskeletal and Skin Diseases Research | 2 | $2.3 million |
| Allergy and Infectious Diseases Research | 1 | $249,935 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $2.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Skin probiotics to treat netherton syndrome - project summary netherton syndrome (NS) is a genetic disorder of significant severity impacting the skin, hair, and immune system. The condition arises from mutations within the SPINK5 gene, responsible for encoding lekti (lympho-epithelial kazal-type in | Arthritis, Musculoskeletal and Skin Diseases Research | September 20, 2024 | $2.0 million |
| Skin probiotics to treat netherton syndrome - project summary netherton syndrome (NS) is a severe genetic disorder that affects the skin, hair, and immune system. Ns is caused by mutations associated with the SPINK5 gene which encodes lekti (lympho-epithelial kazal-type inhibitor), a serine protease | Arthritis, Musculoskeletal and Skin Diseases Research | September 9, 2022 | $249,935 |
| Skin probiotics to treat atopic dermatitis - project summary atopic dermatitis (AD) is a common, chronic inflammatory skin condition characterized by dry, itchy lesions. Current treatments, including immunomodulators and anti-inflammatory steroids, can sometimes control symptoms but may also have SE | Allergy and Infectious Diseases Research | July 1, 2023 | $249,935 |
Questions people ask
How much federal grant money does Resvita Bio Inc get?
$2.5 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Resvita Bio Inc the most?
The Department of Health and Human Services, with $2.5 million in 3 awards.
What is Resvita Bio Inc's largest federal grant?
$2.0 million under Arthritis, Musculoskeletal and Skin Diseases Research, with its first action in the period on September 20, 2024. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Resvita Bio Inc?
Its largest are Arthritis, Musculoskeletal and Skin Diseases Research and Allergy and Infectious Diseases Research.
Other grant recipients in Emeryville
- Bioindustrial Manufacturing and Design Ecosystem
- Grid Alternatives
- Abalone Bio, Inc.
- Engineering Biology Research Consortium
- Eko Health, Inc.
- Cal-Pep
- Topaz Biosciences, Inc.
- City of Emeryville
Largest federal grant recipients in California · Federal grants in California